Schewel Dimitry, Zavareh Milad, Schewel Jury, Thielsen Thomas, Schmidt Tobias, Schäfer Ulrich, Kuck Karl-Heinz, Frerker Christian
Department of General and Interventional Cardiology, Asklepios Clinic St. Georg Hospital, Hamburg, Germany.
Department of General and Interventional Cardiology, Asklepios Clinic St. Georg Hospital, Hamburg, Germany.
Int J Cardiol. 2017 Apr 1;232:147-154. doi: 10.1016/j.ijcard.2017.01.038. Epub 2017 Jan 7.
In high-risk patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) diabetes mellitus (DM) is a common comorbidity. It is known to increase the risk of arteriosclerosis and adversely affect morbidity, mortality for all types of cardiovascular disease, and post-procedural outcome after percutaneous and surgical procedures. Moreover, DM is known to facilitate the genesis of renal failure (RF). Pre-existing RF seems to increase the rate of acute kidney injury (AKI), which is a powerful short- and midterm predictor of mortality in patients undergoing TAVR. Therefore, the aim of the present study was to investigate the impact of DM on AKI, short- and midterm prognosis after TAVR, especially in patients with pre-existing RF.
In 337(30%) of 1109 patients DM was documented. The incidence of RF at baseline (GFR <60mL/min) was statistically similar in both patient groups (no DM vs. DM: 54% vs. 61%; p=0.057). Also, the incidence of AKI stage 3 was similar in all patients (no DM vs. DM: 1.6% vs. 1.8%; p=0.799). There were no significant differences regarding the procedure-related complications according to VARC-2 and mortality between patients neither with nor without DM. Even after differentiating patients according to baseline renal function, similar incidence of AKI and midterm mortality were documented.
In patients undergoing TAVR, neither in case of preserved nor impaired renal function, we couldn't find any evidence for influence of DM on overall acute and midterm prognosis nor the incidence of AKI.
在接受经导管主动脉瓣置换术(TAVR)的高危重度主动脉瓣狭窄患者中,糖尿病(DM)是一种常见的合并症。已知其会增加动脉硬化风险,并对所有类型心血管疾病的发病率、死亡率以及经皮和外科手术后的术后结局产生不利影响。此外,DM还会促使肾衰竭(RF)的发生。术前存在的RF似乎会增加急性肾损伤(AKI)的发生率,而AKI是接受TAVR患者死亡率的有力短期和中期预测指标。因此,本研究的目的是探讨DM对TAVR术后AKI、短期和中期预后的影响,尤其是对术前存在RF的患者。
在1109例患者中,有337例(30%)记录有DM。两组患者(无DM组与DM组)基线时RF的发生率(肾小球滤过率<60mL/分钟)在统计学上相似(54%对61%;p=0.057)。此外,所有患者中3期AKI的发生率也相似(无DM组与DM组:1.6%对1.8%;p=0.799)。根据VARC-2标准,有无DM的患者在手术相关并发症和死亡率方面无显著差异。即使根据基线肾功能对患者进行区分,AKI的发生率和中期死亡率也相似。
在接受TAVR的患者中,无论肾功能正常与否,我们均未发现任何证据表明DM会影响总体急性和中期预后以及AKI的发生率。